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                                                      ABSTRACT 
Enteroviruses are transmitted between individuals mainly via the oral-faecal route and 
they have been associated with clinical syndromes such as meningitis, encephalitis, 
myocarditis, common cold, poliomyelitis and many others. Enterovirus virions 
excreted into sewage can remain infectious for several weeks. Circulation of 
enteroviruses in sewage is a marker of their presence in a particular community and 
hence sewage monitoring can be a complementary approach to assess their prevalence 
in a population. Sewage surveillance also offers the additional advantage of identifying 
circulating enteroviruses that are either subclinical or are yet to be presented clinically. 
The discovery of wild type 1 poliovirus in Israel in 2013, 11 years after the country 
was declared Polio-free by the World Health Organisation (W.H.O.) is an example of 
why sewage surveillance is essential. 
 
Currently, there is limited data on circulating enteroviruses in the Greater Edinburgh 
area. A six month study was conducted (March 2014 to September 2014) to detect the 
types of enteroviruses in the sewage of the city through sewage screening, understand 
their temporal patterns and assess whether these types are clinically significant. 
Sewage sludge collected every fortnight from the Seafield Sewage Water works, a 
sewage facility that serves the inhabitants of the city were filtered and concentrated. 
RNA was eventually extracted from the viral concentrates after which RT-PCR, 
cloning and sequencing of colonies were performed. Serotypes were identified by 
sequence BLAST and phylogenetic analysis. 
 
 During the study, 31 different serotypes were detected and the most common ones 
were Coxsackievirus B5 (CVB5), CVB2, CVA22, CVA4, CVA9, Echovirus 11 (E11), 
E7, E30 and E18. Enterovirus C104, a rare serotype detected in sewage in June 2014 
has been associated with respiratory tract infections in countries like Italy, Switzerland 
and Japan. Also, CVA6 serotype which was identified in several patients with hand 
foot and mouth disease in Edinburgh in February 2014 was also detected in sewage 
collected in March 2014. The detection and characterisation of enteroviruses in sewage 
is an additional resource to enterovirus surveillance and can help explain enterovirus 
associated disease trends and warn of possible future outbreaks in the area 
MSc-Res Infection and Immunity     The University of Edinburgh         2015 ‐ 15 ‐
 







































Enteroviruses are single stranded positive sense RNA viruses that infect a range of 
mammalian species including humans. Belonging to the Picornaviridae virus family, 
infection in human beings can result in a wide range of clinical manifestations such 
as respiratory illnesses (common cold), hand foot and mouth disease, aseptic 
meningitis, acute flaccid paralysis, neonatal sepsis and many others. Transmitted 
mainly via the oral-faecal route, they undergo replication mostly in the gastro-
intestinal tract.  The majority of enterovirus infections in humans beings are either 
subclinical (asymptomatic) or accompanied by mild symptoms (Mueller et al., 2005). 
Enteroviruses are among the most common viruses that infect human beings (Nix et 
al., 2006). 
 
1.2. CLASSIFICATION HISTORY 
Depending on the infectious properties of the virus, such as its pathogenicity in mice, 
enteroviruses were originally divided into four subgroups, namely echovirus, 
poliovirus, coxsackie A virus and coxsackie B virus. However, subsequent analysis 
indicated that the phylogenetic basis for these subgroups in some cases were flimsy 
especially as different strains of an Enterovirus serotype may exhibit different 
pathogenicities in a mouse system. This consequently confused the subgrouping 
based on pathogenicity (Hyypia et al., 1997). It was also later realized that there were 
significant overlaps in the biological properties of viruses in these four groups and 
this ultimately led to a new classification system of consecutive numbers for more 
recently isolated viruses such as Enterovirus 71 (Oberste et al., 2002). 
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1.2.1. Poliovirus: Polioviruses are neurotropic enteroviruses and causal agents of the 
clinical condition in primates known as paralytic poliomyelitis. The propensity for 
poliovirus to specifically target the motor neurone upon infection to cause paralysis 
is actually rare. In fact, only about 1 in 100 cases of infection with poliovirus leads to 
virus invasion of the central nervous system and replication in the neurone resulting 
in paralytic poliomyelitis. The types of paralytic poliomyelitis include spinal polio 
which affects the spine, bulbar polio which affects the brainstem, and bulbospinal 
polio which affects both the spine and brainstem (Ren and Racaniello, 1992). The 
discovery and introduction of the inactivated vaccine (Salk et al., 1954) and the live 
attenuated oral vaccine (Sabin, 1957) has proved to be very efficient in drastically 
reducing the incidence of poliomyelitis across the globe.  
1.2.2. Echovirus (ECHO - Enteric Cytopathic Human Orphan): Echoviruses were 
first isolated from the faeces of asymptomatic children and these viruses produced 
cytopathic effects in cell cultures. They however failed to cause detectable 
pathologic lesions in suckling mice despite the cytopathic effect. As they did not 
show any pathogenic properties in experimental animals, they were named ECHO 
(Enteric Cytopathogenic Human Orphan) viruses (Hyypia et al., 1997). Initially 
thought to be an orphan virus, it was later realised that individual serotypes were 
associated with a wide range of clinical manifestations in human beings such as 
aseptic meningitis, acute febrile illness and myocarditis. Overall, 34 Enterovirus 
serotypes have been assigned as echoviruses. However, Echovirus 28 has been 
reclassified as Rhinovirus 1 whereas E22 and E23 due to their distinct genetic 
features have also been re-assigned to the human parechovirus 1 and 2 respectively 
(Harvala and Simmonds, 2009). 
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1.2.3. Coxsackieviruses: These are a group of non-polio enteroviruses which have 
been associated with a range of clinical conditions that lead to severe morbidity and 
mortality, particularly in infants and children (Tebruegge and Curtis, 2009). Infants 
infected with Coxsackievirus have been shown to be susceptible to diseases like 
myocarditis, meningitis and encephalitis with a mortality rate as high as 10% 
(Rhoades et al., 2011). Coxsackievirus A6 for example is also known to be the cause 
of hand foot and mouth disease as well as myocarditis in infants (Puenpa et al., 
2013). 
In adults, studies have linked Coxsackievirus infection during pregnancy to an 
increase in the rate of spontaneous abortions, foetal myocarditis (Ornoy and 
Tenenbaum, 2006), and neurodevelopmental delays in new-borns (Euscher et al., 
2001). Coxsackieviruses were discovered when suckling mice developed paralysis 
after being inoculated with faecal suspensions of patients who were suspected of 
having poliomyelitis but tested negative for poliovirus (Gear, 1984). The symptoms 
were distinguished from poliomyelitis because the damage responsible for limb 
paralysis was rather due to widespread lesions in the skeletal muscles and not as a 
result of virus invasion in the central nervous system as in poliomyelitis. 
Coxsackieviruses are divided into two groups based on their pathogenicity to 
suckling mice. Coxsackie A virus causes flaccid paralysis whereas coxsackie B virus 
causes spastic paralysis (Oberste et al., 2003). Coxsackie A virus currently has about 
23 serotypes, and is associated with conditions that affect the skin and mucous 
membrane like hand foot and mouth disease, herpangina and acute haemorrhagic 
conjunctivitis. Coxsackie B virus on the other hand currently has 6 serotypes and it is 
associated with diseases like pleurodynia and pericarditis (Schmidt et al., 1973). 
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1.3. TAXONOMY OF ENTEROVIRUSES 
The advancement in genome science especially sequencing ultimately led to a new 
method of classifying enteroviruses. Enteroviruses are currently classified based on 
the virus genomic structure rather than pathogenicity in their hosts.  
As at now, the genus Enterovirus comprises of hundreds of serotypes which have 
been distinguished into 12 species namely; Enterovirus A, Enterovirus B, 
Enterovirus C, Enterovirus D, Enterovirus E, Enterovirus F, Enterovirus G, 
Enterovirus H, Enterovirus J, Rhinovirus A, Rhinovirus B and Rhinovirus C. Only 
Enterovirus A - D and Rhinovirus A-C are relevant to human infection and disease. 
The species of Enteroviruses relevant to human infection and their corresponding 
serotypes are shown in table 1.3a. As observed from this table, the name of the 
serotype is not necessarily an indication of what species it belongs to. Serotypes 
Coxsackievirus A8 (CVA8), CVA9 and CVA22 for example belong to Enterovirus 
A, B and C respectively despite the fact that they are all in the coxsackievirus A 
subgroup. This is simply because, nomenclature was assigned to the serotypes based 
on their pathogenicity to suckling mice prior to classifying enteroviruses into species 
A-D. However, Echovirus and Coxsackievirus B serotypes all belong to Enterovirus 
B. The three poliovirus serotypes (PV1, 2 and 3), have all been classified into 
Enterovirus C. 
Species of rhinoviruses on the other hand are the predominant causal agents of 
common cold. Rhinoviruses were originally classified as a different taxonomical 
genus also belonging to the Picornaviridae family. However, in 2005 Rhinovirus 
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species A, B and C were assigned to the Enterovirus genus by the International 
Committee on the Taxonomy of Enteroviruses (Stanway et al., 2005). 
 




1.4. MOLECULAR BIOLOGY 
The infectious particle (virion) is about 30nm in diameter and is composed of a 
capsid protein which surrounds and protects its RNA genome. The capsid has an 
icosahedral symmetry and consist of four capsid proteins namely VP1, VP2, VP3 
and VP4 each of which is repeated sixty times to form the virion (Shih et al., 2004). 








Coxsackievirus A2, A3, A4, A5, A6, A7, A8, A10, A12, A14, A16. 




Echovirus 2, 3, 4, 5, 6, 7, 9, 11, 12, 13, 14, 30 
Enterovirus B69, 73, 74, 75, 77, 78. B82, B83, B84, B85 




Coxsackievirus A1, A11, A13, A14, A19, A20, A21, A22, A24, 
Enterovirus C95, C96, C99, C102, C104, C105, C109, C113, C116, C117, C118. 
Poliovirus 1, 2 and 3. 
     
 Enterovirus D 
 





Human Rhinovirus A2, A7, A10, A59, A60, A61, A62, A63, A64, A11, A12, A13, 




Human Rhinovirus B3, B4, B5, B6, B14, B17, B26, B27, B35, B37, B42, B48, 




Human Rhinovirus C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, 
C14, C15 etc. (55 Serotypes) 
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capsid proteins and the RNA of the virus. The RNA molecule is about 7.5kb long 
and it is characterised by a VPg protein at the 5’ end, an open reading frame and a 
poly-adenylated tail at the 3’ end. All four capsids have similar structures ( an 8-
stranded anti-parallel beta barrel). VP1, VP2, VP3 and VP4 (entirely on the interior 
as shown in 1.4a) bind together to form a protomer. The protomer is repeated five 
times to form a pentamer and the pentamer is repeated twelve times to form the 
icosahedral virion (Hogle et al., 1985). 
      
Figure 1.4a and 1.4b; schematic structures of enterovirus virion. 1.4a shows a 
disected view with the RNA genome and the capsid proteins whilst 1.4b shows the 
icosahedral structure. VP4 as shown in the diagram is exclusively on the interior 
(Diagram from Swiss Institute of Bioinformatics, not.dated) 
 
When the RNA genome of the enterovirus is ultimately released into a susceptible 
and permissive cell upon infection, it is translated into the precursor proteins P1, P2 
and P3 (polyproteins). These polyproteins are further processed to form the 
individual capsid and non-structural proteins. This is illustrated in a schematic 
diagram of the poliovirus genome is shown in figure 1.4c 
1.4a 
1.4b
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Figure 1.4c: Schematic representation of poliovirus genome from the polyproteins to 
the individual capsid and non-structural proteins (Jacobs et al., 2013). VP4, VP2, 
VP3 and VP1 constitute the capsid (structural) proteins encoded by the P1 precursor. 
The non-structural proteins include proteinases 2A and 3C and the 3Dpol which is an 
RNA-dependent RNA polymerase. 
 
 
Replication cycle is first initiated by binding of the virion to its receptor, followed by 
internalisation into the infected cell and uncoating of the capsid protein to release the 
genomic RNA. The genome is translated into the polyprotein which is eventually 
cleaved to form the individual capsid and replication (non-structural) proteins (van 
der Linden et al., 2015) as shown in Figure 1.4d. The non-structural proteins encoded 
by the virus are responsible for RNA replication through several protein-protein 
interactions between viral and/or host proteins to mediate RNA synthesis, induce the 
membranous vesicles and deliver the replication complex to the template (Sean and 
Semler, 2008). RNA replication occurs in the membranous vesicles that are induced 
upon infection. 




Figure 1.4d: Schematic diagram showing attachment and entry of viable virion into 
the cell, the replication process and the eventual cell lysis to release of new virions 
(van der Linden et al., 2015) 
 
Replication is initiated by uridylylation of the VPg (3B) protein by the 3DPol using 
the cis-acting RNA element (CRE) which is a stem loop structure as a template. The 
uridylylated VPg serves as a ‘primer’ binding to the poly-adenylated tail. It is then 
elongated by the 3Dpol to produce a negative RNA strand which then serves as an 
intermediate for the synthesis of more positive RNA strands. These positive RNA 
strands may either enter another round of translation or be packaged into capsids to 
produce virions (van der Linden et al., 2015). Replication occurs outside the nucleus 
and the virions are released from the cell by cell lysis into the gastrointestinal tract. 
Virions are eventually excreted mostly by faecal egestion. 
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1.5. RECOMBINATION AND MOLECULAR TYPING 
One of the major characteristics of enteroviruses is their ability to undergo 
recombination. The widely recognised model for recombination in enteroviruses is 
the ‘copy choice’ mechanism. According to this model, the RNA-dependent RNA 
polymerase (RdRp: 3Dpol in terms of enteroviruses) switches from one RNA 
molecule to another RNA molecule while remaining bound to the nascent nucleic 
acid chain, consequently generating an RNA molecule with mixed ancestry during 
replication. The presence of secondary structures in the RNA,  the kinetics of 
transcription and extent of local sequence identity between the RNA templates are 
some of the factors that influence template switching and recombination (Simon-
Loriere and Holmes, 2012). Recombination contributes to the high level of genetic 
variations observed in enteroviruses and can affect their evolution as well as viral 
pathogenesis (Lowry et al., 2014). It has been reported that recombination occurs 
mostly in the region of the Enterovirus genome that encodes the non-structural 
proteins. Some recombination have been reported in the 5’ non coding region and 
VP4 region but at a lesser frequency compared to the non-structural genes. There are 
very few reports of recombination in the genes that encode the structural proteins 
VP1, VP2 and VP3. In a study assessing recombination in circulating enteroviruses 
at the 3D, VP1, 2A and 5’UTR genomic regions, strains of the same serotype 
clustered together in a phylogenetic tree only when the sequences in the VP1 
genomic region was used. These suggests that the 5’UTR, 3D and 2A are more likely 
to undergo recombination and are hence not suitable for molecular typing of 
Enteroviruses (Lukashev et al., 2003) 
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Initially, human enteroviruses were antigenically identified by antibody 
neutralisation tests (serology). Despite this process being generally reliable, it is 
labour intensive and in some cases may fail to identify the serotypes of a clinical 
isolate due to mitigating factors like antigenic drift, virus mixtures in specimens 
being tested and genetic recombination in the virus (Oberste et al., 1999a). It was 
suggested that the sequence of the capsid region VP1 should correspond with 
phylogenetic lineage since it contains a number of neutralisation domains (Oberste et 
al., 1999b) and is less likely to undergo recombination. Currently, human enterovirus 
types are identified by full or partial sequence on the VP1 or by seroneutralisation 
(Caro et al., 2001). 
Identification with sequences from different regions other than the VP1 region can be 
useful as well. Targeting sequences of VP2 and VP4 capsid regions as an alternative 
method to type enteroviruses have been described (Nasri et al., 2007b). A study by 
Perera et al suggested that the nucleotide sequence encoding the VP2 protein could 
also be used for molecular typing of enteroviruses (Perera et al., 2010). The genome 
that codes for the VP4 region is however not reliable for typing.  
 
1.6. DISEASE MANIFESTATIONS AND COST 
Enteroviruses are genetically diverse with over 300 serotypes, about many of which 
are known to infect human beings. More recently, outbreaks of infections from 
Enterovirus D68 in several parts of the world have been associated with severe 
respiratory illnesses mostly in people with asthma (Midgley et al., 2015).  
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Absenteeism from work or reduction in productivity at work due to a symptomatic 
infection, hospitalisation, effects on social life, costs associated with eradication 
initiatives and costs associated with purchasing treatment medicines contribute to the 
economic ramifications of Enterovirus infections.  Common cold for example is 
caused mostly by viral respiratory tract infections and is the most common illness in 
human beings (Frederick et al., 2003). Human rhinovirus species have been 
demonstrated to cause about 50% to 67% of all common cold symptoms (Mikaela et 
al., 1998, Arruda et al., 1997). Symptoms associated with common colds include 
rhinorrhoea, nasal congestion, sore throat, headache, malaise and cough. Common 
colds constitute a global health problem which affects activities like sleep, work 
performance, school and social life regardless of gender or age. In a study conducted 
in the United States in October 2001, the economic cost as a result of the common 
cold was estimated to be about $25 billion annually of which $16.6 billion was 
attributed to ‘on the job productivity loss’ (Bramley et al., 2002). 
One of the most severe clinical manifestations that result from Enterovirus infection 
is poliomyelitis that could lead to partial or full paralysis. After the discovery of the 
polio vaccines, a number of countries have been declared polio free. Two main types 
of vaccine used are the IPV and OPV. IPV (Inactivated Polio Vaccine) are wild type 
poliovirus strains from the three serotypes which have been killed or inactivated with 
formalin. Also known as the ‘Salk vaccine’, it is administered by intramuscular 
injection. Since IPV is not live, it carries no risk of vaccine associated polio or any 
systematic adverse drug reaction. Although IPV is quite effective in conferring 
immunity, levels of intestinal immunity is quite low and as a result, immunised 
people infected with polio can still shed the virions through defaecation thereby 
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risking continued circulation. Shedding of poliovirus strains in faeces as a result low 
levels of immunity in the intestines means that it is possible to detect poliovirus in a 
sewage screen even if it has not been presented clinically for a considerable period. 
OPV on the other hand also known as ‘Sabin vaccine’ is a mixture of live attenuated 
or weakened poliovirus strains from the three serotypes and this confers immunity to 
the vaccinated person. Administered orally and relatively inexpensive compared to 
IPV, intestinal immune response to OPV is comparatively better and this means that 
mass vaccination can rapidly stop transmission of wild polio from an infected person 
to another. However, in some rare cases, OPV can cause paralysis  
In countries where the disease remains endemic like Pakistan, Afghanistan and Syria, 
civil issues such as war have disrupted vaccine dissemination to the wider 
communities. Global Eradication Initiative projects that approximately $5.5 billion 
will be required to finance the eradication programme between 2013 and 2018 
(Global Polio eradication initiative website, not dated). 
South East Asia in particular have experience large outbreaks of Enterovirus 71 
infections since the late 1990s. Enterovirus 71 which is an Enterovirus A serotype is 
one of the pathogens that cause hand foot and mouth disease (HFMD). This pathogen 
has been responsible for large outbreaks of HFMD outbreaks in Taiwan, Malaysia, 
China, Vietnam and Cambodia since the late 1990s (Sabanathan et al., 2014). In 
1998, a large outbreak of Enterovirus 71 in Taiwan resulted in 78 deaths. Subsequent 
smaller outbreaks recurred in 2000 and 2001. The outbreaks was recognised due to 
the large number of HFMD cases and the rapid deaths of young people who were 
affected (Lin et al., 2008). Also, in Cambodia, 58 deaths were recorded in children as 
a result of Enterovirus 71 outbreak between April and July 2012. The symptoms 
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were initial encephalitic presentation followed by destructive alveolar pneumonia 
which was rapid and often fatal (Sabanathan et al., 2014). Enterovirus 71, was first 
isolated in 1969 in the state of California (Schmidt et al., 1974) and since then, they 
have been isolated in many parts of the world. Large and small outbreaks of this 
pathogen since the late 1990s demonstrates the emergence and persistence of 
Enterovirus 71 related diseases especially in South East Asia. There are no available 
vaccines against Enterovirus 71 at the moment. Guidelines on how to manage hand 
foot and mouth disease has however been published by the World Health 
Organisation (WHO press, 2011). Enterovirus 71 has also been associated with 
diseases like aseptic meningitis, encephalitis and cardiopulmonary dysfunction 
(Perez-Velez et al., 2007) 
 
1.7. THESIS 
As there are so many Enterovirus serotypes that cause a wide range of clinical 
syndromes, monitoring trends of Enterovirus infections in an area is important in the 
attempt to understand their temporal and geographical pattern. If people exhibiting 
clinical symptoms visit a medical facility and undergo medical diagnostic tests, data 
representing the serotypes circulating in an area can be obtained as part of 
Enterovirus surveillance. The major limitation to this form of surveillance is the fact 
that many Enterovirus infections are asymptomatic and hence such data will not be 
comprehensive. Taking poliovirus infection for example, only about one in hundred 
individuals infected with the virus will go on to exhibit paralytic symptoms. 
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Therefore, if there is no paralytic polio presentation clinically for some time, it does 
not necessarily mean that the virus is not circulating in the community.  
The main mode of transmission of enteroviruses is the oral-faecal route and most 
infected people shed large amounts of virus in faeces for several days or weeks, both 
before and after onset of symptoms. Due to their stable capsid structure and 
conformation as well as their ability to withstand adverse conditions, virions of 
enteroviruses excreted into sewage can remain infectious for a considerable length of 
time. Circulation  of enteroviruses in local sewage is therefore a marker of their 
presence in a particular community (Zheng et al., 2013). Screening of sewage in a 
local area for the presence of enteroviruses would yield a more comprehensive data 
which will include strains that have not been presented clinically or asymptomatic. 
An example was the detection of wild type 1 poliovirus in a routine sewage screen 
from samples collected between the 7th and the 13th  April 2013 in Southern Israel. 
Analysis of the strain indicated that it was introduced into that area in early February 
2013 despite the fact that Israel had been declared Polio free since 2002 by the World 
Health Organisation (WHO). National supplementary immunisation with oral polio 
vaccine was consequently started in August 2013 (Anis et al., 2013). 
Currently, there is limited data on circulating enteroviruses in the Edinburgh and no 
sewage surveillance to ascertain the types of enterovirus in the local area is being 
performed. With Seafield Treatment Waste Water Works serving as the sewage 
treatment centre for the city and its surroundings, a screen of sewage collected from 
there could equip us with the necessary information about the types of enteroviruses 
circulating in the city. The aim of this thesis was therefore to identify the Enterovirus 
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strains circulating in Edinburgh at different time points, assess what the temporal 
pattern and find out if they are clinically significant. 
Enteroviruses were typed with the VP4 and partial VP2 genomic sequences after 
RNA extraction, RT- PCR, cloning and colony sequencing. Sequences were edited 
and aligned with the software SSE 1.2. Serotype identification was through the 
online algorithm BLAST and phylogenetic analysis (with MEGA6 software) to 


























Materials and methods applied in this project were in two main categories: 
i. Processing of sewage samples collected from Seafield Treatment Waste 
Water Works facility (laboratory based) 
ii. Construction of datasets of DNA sequences and with the online algorithm 
BLAST to identify, the software SSE 1.2 to edit and align the sequences and 
the programme MEGA6 to perform test of phylogeny (In Silico based) 
 
2.1. MATERIALS 
2.1.1. Kits Used 
i. SuperScript® III One-Step RT-PCR system with Platinum® Taq DNA 
Polymerase (Invitrogen; Catalogue # 12574-018) 
ii. QiaAmp Viral RNA mini kits (Qiagen; Catalogue # 52904) 
iii. QIAquick Gel Extraction Kit (Qiagen; Catalogue # 28704) 
iv. pGEM®-T and pGEM®-T Easy Vector Systems (Promega; Catalogue # 
A1360) 
v. BigDye®  Terminator v3.1 Cycle Sequencing Kit (Catalogue number: 
4337455) 
vi. GoTaq® G2 DNA Polymerase (Promega, Catalogue # M7841) 
 
2.1.2. Machines 
i. PCR Machine (Bibby Scientific; Techne TC-4000) 
ii. Falcon 6/300 bench centrifuge (Product code: 12730616) 
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iii. New Brunswick INNOVA 4300 Series Shaker Incubator 
iv. NanoDrop 1000 Spectrophotometer (NanoDrop Technologies V 3.7) 
v. Eppendorf Centrifuge, Minispin/Minispin plus Microcentrifuge (Sigma-
Aldrich, Product # Z606235) 
vi. Rotor Gene- Q qPCR machine (QIAGEN; System serial number R0910 117) 
vii. Heraeus Fresco 17 Centrifuge ( Thermo electron corporation Catalogue # 
75002420) 
viii. G:Box Transilluminator (Syngene) 
ix. Safe Imager Transilluminator (Invitrogen model S37102) 
 
 
2.1.3. Reagents and Enzymes  
i.         RNase free Water (Qiagen; Catalogue 129112 )   
ii. 10mM dNTP (Deoxyribonucleotide triphosphate) 
iii. RNA storage solution (Ambion UK, AM7001) 
iv. LB Broth and LB Agar (Roslin Institute Laboratory) 
v. E. coli competent cells (DH10β, Roslin Institute Laboratory) 
vi. Ampicillin (Life Technologies; Catalogue number: 11593-027) 
vii. IPTG reagent ( Invitrogen™ Catalogue number: 15529-019) 
viii. X-Gal ( Invitrogen™ Catalogue number: 15520-034) 
ix. 1kbp DNA Marker (Promega, Catalogue # G5711) 
x. SYBR® Safe DNA Gel Stain (Invitrogen™ Catalogue number: S33102) 
xi. UltraPure™ Agarose (Life Technologies Catalogue 16-500-100) 
xii. 10µM DNA Primers (Refer to table 2.1a)  
xiii. 10µM Random Hexamers 
 




i. 50ml Falcon tubes 
ii. 20ml syringe (Terumo Hypodermic; Ref Nos SS+ 20S1) 
iii. 0.45µm syringe filter (Millipore; Catalogue #  SLHV033RS ) 
iv. Centriprep YM-50, 50 kDa NMWL (Millipore, Catalogue # 4310) 
v. Amicon Ultra-0.5 mL Centrifugal Filters (Millipore, Catalogue # 
UFC500308) 
vi. X250 strip 8X tube and Domed caps (Thermoscientific item #10249393   
vii. Petri dishes  
viii. Eppendorf tubes. 
A list of all the primers used in this thesis, their targeting regions and corresponding 
sequences is displayed table 2.1a. 
 









Outer Sense (VP4) 458s CCGGCCCCTGAATGYGGCTAA 
Inner Sense (VP4) 547s ACCRACTACTTTGGGTGTCCGTG 
Antisense (VP4) 1087as TCWGGHARYTTCCAMCACCANCC 
Antisense (VP4) 1178as TCNGGRAAYTTCCARTACCANCC 
Outer Antisense (VP4) 1125as ACATRTTYTSNCCAAANAYDCCCAT 
5’UTR – HEV-FWD 370s GGCTGCGYTGGCGGCCTRC 
5’UTR – HEV-REV 563as ACACCCAAAGTAGTYGGTYCCR 
M13 Forward (pGEM-T) M13F CGCCAGGGTTTTCCCAGTCACGAC 
M13 Reverse (pGEM-T) M13R TCACACAGGAAACAGCTATGAC 
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Composition of materials used in the experiment 
1. Agarose Gel  
i. 2% UltraPure™ Agarose (Life Technologies Catalogue 16-500-100) in 
1 x TAE solution 
ii. 0.0001% SYBR® Safe DNA Gel Stain (Invitrogen™ Catalogue 
number: S33102) 
2. Agar Plates  
i. 0.5mM IPTG,  
ii. 8µg/ml X-Gal  
iii. 100µg/ml of Ampicillin. 

















The experimental design used for this thesis with the aim of obtaining at least 30 
Enterovirus sequences from each time point every fortnight between March 2014 and 
September 2014 is shown in Figure 2.2a.  
 
 
Figure 2.2a: Flow diagram showing the general experimental design for this thesis. 
 
The Seafield Treatment Waste Water works Facility located at 20 Marine Esplanade, 
Edinburgh EH6 7RF was chosen as the site for collection of sewage samples because 
the facility treats waste water and sewage for a population of approximately 850000 
people from Edinburgh which equates to about 300million litres of waste water daily 
from the city. It is hence a suitable source for monitoring enteroviruses circulating in 
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the greater Edinburgh area (waste water treatment and sewage, not dated). Pictures of 
the Seafield treatment water works facility are displayed in figure 2.2b and 2.2c. 
     
Figures 2.2b and 2.2c: Seafield Treatment water works facility at 20 Marine Esplanade, 
Edinburgh EH6 7RF. 
 
About 500ml of sewage sludge was collected and sent to the laboratory for further 
processing every fortnight. Table 2.2d refers to the time points of sewage sample 
collection and their respective dates.  











1 26th March 2014 
2 9th April 2014 
3 23rd April 2014 
4 7th May 2014 
5 21st May 2014 
6 4th June 2014 
7 18th June 2014 
8 2nd July 2014 
9 16th July 2014 
10 30th July 2014 
11 13th August 2014 
12 27th August 2014 
13 10th September 2014 
2.2c2.2b 
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2.2.1. Control (detection limit of assay) 
This was to determine the lowest concentration of viral RNA at which a PCR assay 
would remain sensitive. RNA serial (10 fold stepwise) dilutions of Coxsackievirus A16 
(Enterovirus A), Echovirus 30 (Enterovirus B), Coxsackievirus 21 (Enterovirus C) and 
Enterovirus 70 (Enterovirus D) ranging from 106copies per µl to 10-1 copies per µl  
were prepared and three detection limit assays were performed on each of the 
solutions. To determine the detection limits, RT-PCR (SuperScript® III One-Step RT-
PCR system with Platinum® Taq DNA Polymerase) and second round PCR was 
performed on the solutions and the products were visualised on a 2% agarose gel after 
electrophoresis to find the lowest RNA concentration at which the assay remained 
sensitive.  
The one step RT-PCR reaction converts the viral RNA into cDNA and then amplifies 
the region of interest (VP4/Partial VP2 region) in a single reaction. Second run round 
PCR was performed after the one-step RT-PCR to improve sensitivity and specificity 
of the PCR process.  
2.2.1a Preparation of RNA serial (10 fold stepwise) dilutions 
Enterovirus stocks of Coxsackievirus A16, Echovirus 30, Coxsackievirus A21 and 
Enterovirus 70 RNA representing Enterovirus A-D respectively were obtained from 
the Simmonds group and their respective concentrations were quantified using a 
NanoDrop ND-1000 with quantifying optical density at 260 nm. Assuming that the 
mean molecular mass of each nucleotide base is 330g/mol, the RNA concentrations 
were converted to RNA copy numbers. To prepare the 10 fold stepwise (serial) 
dilutions of RNA in copies per µl for each of the Enterovirus stocks, the RNA was 
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diluted in RNA storage solution (1mM sodium citrate, 0.1mM EDTA, pH 6.0: Ambion 
UK) containing 0.05µg/ml herring sperm carrier RNA and 0.1U/ml RNasin. Serial 
dilutions were either used in downstream reactions or stored at -80oC.  
2.2.1b Assays: amplifying VP4 and partial VP2 region 
In assay 1, a single reaction mix for an RT-PCR contained 10µl of 2X Reaction mix, 
0.7µl of primer 458s (10µM), 0.7µl of primer 1125as (10µM), 0.8µl of SSIII Taqman 
one-step and 3.8µl of nuclease free water. For the second run round PCR, a single 
reaction mix contained 12.7µl of Nuclease free water, 4µl of 5X Buffer Green Go Taq, 
1µl of Primer 547s (10mM), 1µl of Primer 1087as (10mM), 0.2µl of 3mM dNTP, 0.1µl 
of G2 Go Taq and 1µl of RT- PCR product. The cycling conditions are shown in table 
2.2.1b. In assays 2 and 3 however, the only procedural changes were the types of 
antisense primers used. Both assays 2 and 3 were hemi-nested PCR assays and the 
antisense primers used were 1087a and 1178a respectively (same antisense primer 
used in both RT-PCR and second round PCR). The reaction composition, sense 
primers and cycling conditions remained the same.  
Agarose gel electrophoresis was performed using 2% agarose gel (1kbp DNA marker 
as a guide: expected size was 742 base pairs) and the image was visualised using the 
Safe Imager Transilluminator and a GBox gel imager to determine the detection limit 









Table 2.2.1b: Cycling conditions for RT-PCR and second run PCR for the detection limit 
assay 
CYCLING CONDITIONS 
(ONE STEP RT-PCR) 
CYCLING CONDITIONS 
(SECOND ROUND PCR) 




95oC for 15 seconds 
52oC for 30 seconds 





94oC for 2minutes 
95oC for 15 seconds  
40 cycles 52oC for 30 seconds 
68oC for 50seconds 
68oC for 5minutes 1 cycle 
 
 
2.2.2. Filtration and Concentration of Sewage/ RNA extraction 
50ml falcon tube was filled with untreated sewage sludge collected from Seafield 
Treatment Waste Water Works and centrifuged in the Falcon 6/300 Sanyo MSE 
Centrifuge at 1100rpm for 15 minutes to sediment the sewage separating the 
supernatant from the solid particles. The supernatant was then drawn out with a 20ml 
syringe and filtered with a 0.45µm syringe filter (Millipore; Catalogue #SLHV033RS).  
The filtrate was then concentrated using a centriprep (YM-50 50 KDa NMWL:  
Millipore, Catalogue #4310) as described in the manufacturer’s instructions. Further 
concentration to obtain the virus stock was done using Amicon Ultra-0.5 mL 
Centrifugal Filters (Millipore) as described in the Ultra-0.5 mL Centrifugal Filters unit 
protocol 
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After obtaining the virus stock from filtration and concentration, RNA was extracted 




2.2.3. RT-PCR, and Agarose gel electrophoresis 
Three RT-PCR and second round PCR assays were performed on the extracted RNA 
at each time point to amplify the VP4 and partial VP2 regions of Enterovirus genome 
using the same reagents, procedures and cycling conditions described in 2.2.1b.  For 
all the assays, the DNA fragment sizes expected on the agarose gel after the PCR 
process and electrophoresis was 742 bases.  
 
2.2.4. Cloning, colony PCR and sequencing 
2.2.4a. DNA extraction: If DNA fragments (bands) had a size of approximately 742 
bases (using the 1kb marker as a guide), the band was excised under UV light. DNA 
was then extracted from the excised bands with QIAquick Gel Extraction Kit 
according to the manufacturer’s instruction to yield purified DNA. 
2.2.4b. Ligation into pGEM-T-vector: Using the pGEM®-T and pGEM®-T Easy 
Vector Systems, generated purified DNA was ligated into the pGEM-T vector 
according to manufacturer’s instructions 
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2.2.4c. Transformation into E.coli competent cells: 2µl of the ligation mix was pipetted 
into an eppendorf tube containing 50µl of thawed E.coli competent cells (DH10β) and 
this mixture was incubated on ice for 20minutes.  
Then, 42oC heat shock was applied to the mixture for 50 seconds after which the 
mixture was placed back on ice for 2minutes. 900µl of LB Broth was then added and 
the mixture was placed in a 37oC shaker incubator for 75 minutes.  
 
2.2.4d. Plating on the LB Agar/Amp/ IPTG/X-Gal Plates: 150µl of the transformation 
mix was streaked on an LB Agar/Amp/ IPTG/X-Gal plate and the plate was incubated 
overnight at 37oC overnight. The pGEM-T vector has a gene that codes for ampicillin 
resistance and hence, the antibiotic ampicillin in the LB Agar/Amp/IPTG/X-Gal plate 
is to ensure that only E.coli successfully transfected with pGEM-T will be expressed. 
2.2.4e. Blue white screen and colony selection: Several colonies grew on the LB 
Agar/Amp/IPTG/X-Gal plate and these colonies were either bluish or whitish in 
colour. The pGEM- T vector has a Lac Z gene which encodes the protein β-
galactosidase. β-galactosidase hydrolyses X-gal (in the agar plate) by cleaving its β-
glycosidic bond ultimately leading to the expression of 5’5 dibromo-4-4-dichloro 
indigo which is an intensely blue product. If the β-galactosidase is interrupted as a 
result of ligation, this hydrolysis of X-gal will not occur and therefore the blue 
coloured product is not expressed. Ligation interrupts the expression of the gene that 
encodes β-galactosidase meaning that blue colonies were not products of ligation. 
Only whitish colonies hence were selected for colony PCR and sequencing.  
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2.2.4f. Colony PCR: A single colony PCR reaction mix was composed of 13.7µl of 
nuclease free water, 4µl of Buffer Green Go Taq, 1µl of 10µM M13 Forward primer, 
1µl of 10µM M13 Reverse primer, 0.2µl dNTP, 0.1µl of G2 Taq Polymerase and the 
selected colony (whitish colony harvested with a pipette tip and dipped into the 
reaction mix). In a PCR reaction, the M13 forward and reverse primers bind to the 
pUC/M13 forward and reverse sequencing primer binding sites respectively on the 
pGEM-T vector. These sites are adjacent to the DNA insert and hence, a successful 
PCR using the M13 primers will amplify both the M13 regions as well as the DNA 
insert. The expected size of the amplicon after colony PCR was 979 bases. The cycling 
conditions for colony PCR is shown in Table 2.2.4f. 
 






2.2.4g. Sequencing reaction: For each product, two reactions were performed with 
different primers; one with the M13 forward primer and the other with the M13 
reverse primer. Using the BigDye® Terminator v3.1 Cycle Sequencing Kit, the 






95oC for 20 seconds 
55oC for 45 seconds 








Table 2.2.4g: Reaction mix and the cycling conditions used in the sequencing reaction  
SEQUENCING REACTION MIX CYCLING CONDITIONS 
 
8µl      RNase free water 
0.6µl     Big Dye solution 
1µl        10µM M13 primer 
0.4µl     Colony PCR product (979 bases) 
95oC for 10min     Hold 
96oC for 3 sec 
62oC for 15sec      
68oC for 30sec 
 
35 cycles 
72oC for 2min      Hold 
 
Products were shipped to Edinburgh Genomics (Edinburgh Genomics, Ashworth 
Laboratories, Charlotte Auerbach Road, The King’s Buildings, The University of 
Edinburgh, EH9 3FL, Edinburgh, Scotland) where they were sequenced. 
 
2.2.5 BIOINFORMATICS (IN –SILICO BASED) 
Sequences of the colonies were downloaded from the Edinburgh Genomics website in 
text and chromat files. Sequences from the text file were loaded unto the SSE 1.2 
programme where they were edited with critical visual perception using the chromat 
files as a guide. The editing included the removal of the 5’UTR sequences and the 
primer binding sites. After editing, a complete fragment of DNA was about 458 bases. 
Sequences were also loaded unto the BLAST (Basic Local Alignment Search Tool) 
algorithm to be establish the species. BLAST only identifies the sequences on its 
database that best resemble the query sequence.  Species specific phylogenetic analysis 
was then performed to determine the serotypes.  
CHAPTER 2: MATERIALS AND METHODS 
MSc‐Res Infection and Immunity     The University of Edinburgh      2015         46 
 
Phylogenetic analysis are performed to study the evolutionary history of the sequences 
obtained and their relationship to the reference sequences from Genbank which is an 
open access sequence database produced and maintained by the National Centre for 
Biotechnology Information (NCBI).  Using the software for constructing phylogenetic 
trees known as MEGA6 (Molecular Evolutionary Genetic Analysis), neighbour 
joining phylogenetic trees with 500 bootstrap replications using maximum composite 
likelihood and pairwise deletions were constructed to identify serotypes  
2.2.5b. Typing with partial VP2 region - The VP1 region of Enterovirus genome has 
been shown to correlate with their serotypes (Oberste et al., 1999a). However, RT-
PCR targeted the VP4 and partial VP2 regions in all the three assays. VP4 region of 
the Enterovirus genome is highly prone to recombination (Lukashev et al., 2003) and 
therefore not reliable for molecular typing. Sequences of Enterovirus species detected 
in sewage were 458 nucleotide bases long (the first 203 for the VP4 region and 255 
bases from the VP2 region). To test whether the first 255 nucleotide sequences of the 
VP2 region were sufficient for molecular typing, sequences of human enteroviruses 
were downloaded from Genbank and phylogenetic trees were constructed using the 
first 255bases of their VP2 region to assess whether sequences from the same serotype 
clustered together.  
2.2.5b Identifying serotypes:  After editing the sequences from the sewage, they were 
aligned with reference sequences for all the established human Enterovirus species 
using the SSE 1.2 software. The first 255 bases from the VP2 region were selected for 
phylogenetic analysis to identify the serotypes and generate the relevant data for this 
thesis.  
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3.1. LABORATORY BASED RESULTS 
 
The detection limit for all the three assays was determined to be 101 RNA copies per 
µl for Enterovirus A-D. Similar sensitivities across the four species meant that the rate 
of detection will not significantly lead to bias selection during PCR. Figure 3.1a is a 
diagram showing the agarose gel results from the detection limit assay for assay 1. All 
three assays showed similar results. 
  
Figure 3.1a shows the detection limit assay visualised on an agarose gel. These were 10 fold 
stepwise dilutions of RNA (106 to 10-1 copies per µl) 
 
All 13 pre-treatment sewage samples were RT-PCR positive for human enteroviruses 
in all the three assays. Figure 3.1b is the result of agarose gel electrophoresis after RT-
PCR and second round PCR. Expected DNA size was 742 bases 
 
Figure 3.1b: Agarose gel photo for assay 3. All 13 time points were positive for human 
enteroviruses. 
Coxsackievirus A16 (EV- A) 
Echovirus 30 (EV- B) 
Coxsackievirus A21 (EV- C) 
Enterovirus 70 (EV- D) 
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After the Blue white screen, colony PCR was performed. Figure 3.1c shows the result 
of the second time colony PCR for assay 3. 
 
 
Figure 3.1c: result of a colony PCR on an agarose gel.  
 
PCR products whose band size on an agarose gel were approximately 979 bases were 
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3.2. IN SILICO BASED RESULTS 
After sequence BLAST, it became clear that none of the serotypes identified belonged 
to Enterovirus D. This was not a surprise as Enterovirus D species are largely 
respiratory tract infections. Apart from the conspicuous absence of Enterovirus D, 
serotypes from all the other Enterovirus species were identified in the sewage samples 
collected across the 6 months study period. 
3.2.1a. Testing VP2 for molecular typing: Due to the high level of sequence 
diversity, designing primers that anneal specifically to the genome to amplify the VP1 
genomic region for all the species of enteroviruses is quite challenging. Although RT-
PCR to amplify the VP4 and partial VP2 regions were sensitive at 101 copies/μl of 
RNA for Enterovirus A-D in the detection limit assays, the VP4 region is more prone 
to recombination and is therefore not reliable for molecular typing.  The VP4 and 
partial VP2 genomic regions targeted by the RT-PCR was about 458 nucleotide bases 
long (first 203 bases for VP4 and the next 255 bases for partial VP2) after editing. To 
test whether the first 255 nucleotide bases in the VP2 region was sufficient for 
molecular typing, reference sequences (refseq) of established human Enterovirus 
serotypes across species A, B and C were downloaded from Genbank and phylogenetic 
analysis were performed with the first 255 nucleotide bases of the VP2 genomic region 
to assess whether sequences from the same serotype clustered together (Enterovirus D 
was ignored as there were no serotypes identified in sewage). As shown in Figure 
3.2.1.ai (Enterovirus A), 3.2.1aii (Enterovirus B) and 3.2.1aiii (Enterovirus C), 
sequences from the same serotype clustered together meaning that the first 255 
nucleotide bases of VP2 region could be used for molecular typing.  






Figure 3.2.1ai: The first 255 nucleotide bases in the VP2 regions of Enterovirus A serotypes 
in a neighbour- joining tree. VP2 sequences from the same serotypes cluster together. This 
means that the partial VP2 region displays 100% concordance with their respective serotypes 






































































































































































































































































































































































Figure 3.2.1aii: The first 255 nucleotide bases of the VP2 regions of Enterovirus B serotypes 
in a neighbour- joining tree. VP2 sequences from the same serotypes cluster together. This 
means that the partial VP2 region displays 100% concordance with their respective serotypes 























































































































































































































































































































































































































































































































































Figure 3.2.1aiii: The first 255 nucleotide bases of the VP2 regions of Enterovirus C serotypes 
in a neighbour- joining tree. VP2 sequences from the same serotypes cluster together. This 
means that the partial VP2 region displays 100% concordance with their respective serotypes 
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3.2.1b. Serotype identification and distribution: After sequences of colonies were 
obtained from Edinburgh Genomics and identified by BLAST, they were grouped into 
their respective species (Species A, B, C and Rhinovirus) for each time point. After 
alignments with reference sequences for all established human enteroviruses, the 
serotypes were identified by phylogenetic analysis. Figure 3.2a, 3.2b and 3.2c shows 
phylogenetic trees used to identify serotypes detected in sewage that was collected on 
the 26th of March 2014 (time point 1) 
 
     
Figures 3.2a and 3.2b: Phylogenetic trees (neighbour joining trees) to identify serotypes using 
255 bases of the VP2 genome region. Sewage samples were collected on the 26th of March 
2014. 3.2a is for the serotypes belonging to Enterovirus C whereas 3.2b are for serotypes 























































































































Figure 3.2c: Phylogenetic tree to identify the Enterovirus B serotypes detected in sewage 
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A total 598 sequences were obtained constituting 31 serotypes (7 belonging to 
Enterovirus A, 16 to Enterovirus B and 8 to Enterovirus C) across the three assays. 
Some Rhinoviruses were also identified.  
Despite the fact that the detection limit was 101 RNA copies per µl, it was a bit 
surprising that no Enterovirus A serotypes were picked up in assay 1. Apart from that, 
there were a few instances (time point 8, time point 12 and time point 13) where only 
Coxsackievirus A22 strains were detected in that same assay. A careful examination of 
the in house primer 1125a (outer antisense primer) showed that there was a mismatch 
in the first three bases of the primer at the 5’ end with the primer binding site of 
Enterovirus A species with the exception of Coxsackievirus A16 which is why the 
detection limit assay worked. There was therefore preferential binding to other 
Enterovirus species. Assays 2 and 3, both hemi-nested were performed and they were 
more sensitive to Enterovirus A serotypes in the same region. 
Merging the three assays, at least 30 sequences were obtained for each time point. The 
serotypes identified and their percentage abundance at each time point is illustrated in 
Figures 3.2.1a to 3.2.1m. 




Figure 3.2.1a; Percentage frequencies of identified serotypes at time point 1 
 
  























































































































Percentage frequencies of detected serotypes on 26th 






















































































































Percentage frequencies of detected serotypes on 7th 
April 2014 (Time point 2) n= 60






























































































































Percentage frequencies of detected serotypes on 23rd 






















































































































Percentage frequencies of detected serotypes on 7th May 
2014 (Time point 4) n=59





Figure 3.2.1e; Percentage frequencies of identified serotypes at time point 5 
 
 

















































































































Percentage frequencies of detected serotypes on 21st 

























































































































Percentage frequencies of detected serotypes on 4th 
June 2014 (Time point 6) n = 54





























































































































Percentage frequencies of detected serotypes on 18th of 

















































































































Percentage frequencies of detected serotypes on 2nd
July 2014 (Time point 8) n = 46







Figure 3.2.1i; Percentage frequencies of identified serotypes at time point 9 
 
 






















































































































Percentage frequencies of detected serotypes on 16th 





















































































































Percentage frequencies of detected serotypes on 30th 
July 2014 (Time point 10) n =44




Figure 3.2.1k; Percentage frequencies of identified serotypes at time point 11 
 
 





















































































































Percentage frequencies of detected serotypes on 13th 





















































































































Percentage frequencies of detected serotypes on 27th 
August 2014 (Time point 12) n = 31




Figure 3.1m; Percentage frequencies of identified serotypes at time point 13 
 
3.2.1c. Assessment of Results: Coxsackievirus A22, an Enterovirus C serotype was 
identified in all the samples except in the time point 11. It is however difficult to state 
definitively that it was the dominant serotype since over 50% of assay 1 serotypes 
identified were Coxsackievirus A22 (CVA22). Enterovirus C104, a rare serotype was 
identified in sewage collected on the 4th and 18th of June 2014 (Figures 3.2.1f and 
3.2.1g). Enterovirus C104 has been associated with some cases of respiratory tract 
infections in Italy, Japan, Switzerland and China (Xiang et al., 2014). The fact that it 
was only identified in early summer when respiratory tract infections usually peaks is 
an interesting coincidence 
The fewest number of serotypes were identified on the 23rd of April 2014. This is 





















































































































Percentage frequencies of detected serotypes on 10th 
September 2014 (Time point 13) n =37
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4.76% of the sequences detected in from sewage on the 26th of March 2014 were 
identified as CVA6. (Refer to Figure 3.2.1a). Coincidentally, CVA6 was identified in 
all typed cases of hand foot and mouth disease in Edinburgh between January and 
February 2014 (Sinclair et al., 2014). Identification of this virus in sewage underscores 
the fact that enteroviruses circulating in sewage are a marker for their prevalence in a 
particular community (Zheng et al., 2013). 
Some of the serotypes detected in sewage have been implicated in several disease 
manifestations. Echovirus 30 for instance was identified to be the causative agent of 
aseptic meningitis outbreak in some parts of Finland particularly between August 2009 
and September 2010 (Österback et al., 2015). Also, Echovirus 11 a largely 
asymptomatic virus can cause a wide variety of clinical conditions like gastroenteritis, 
meningitis and encephalitis (Rubinstein et al., 2000). Furthermore strains of both 
CVB5 and CVA10 have been associated in several outbreaks of hand foot and mouth 
disease in parts of South East Asia (Lu et al., 2012; Hu et al., 2012). 
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4.1. Project aim  
The aim of this study was to identify the types of enteroviruses circulating in 
Edinburgh at different time points through sewage screening, assess their temporal 
patterns and find out whether the detected serotypes were clinically significant. To 
do this, three RT-PCR assays were performed to amplify the VP4 and partial VP2 
regions of enteroviruses after which the PCR products were cloned, sequenced and 
identified by online BLAST and phylogenetic analysis.  
4.2. Background 
Enteroviruses are quite diverse and many of their serotypes can infect human beings. 
Diagnosis at hospitals provides some insight into the types that are circulating in a 
particular area. However, many infections are subclinical and therefore an attempt to 
find the types of enteroviruses circulating in the city will not be very comprehensive 
if clinical diagnosis is the only way of studying enterovirus circulation. This study 
shows that, regular screening of sewage can give comprehensive information about 
the types of enteroviruses circulating in the city. Several studies monitoring 
community sewage for enteroviruses has been demonstrated in different parts of the 
world. In Wisconsin, USA, clinical isolates were compared with sewage isolates 
between August 1994 and December 2002 and it showed that the most commonly 
detected serotypes in sewage were similar to the most commonly detected serotypes 
in clinical specimens (Sedmak et al., 2003). A study as well by Harvala et al also 
found similar pattern except that Enterovirus C serotypes were diverse in sewage but 
absent in in clinical specimens (Harvala et al., 2013). The detection and 
characterisation of enteroviruses in sewage is an additional resource to enterovirus 
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surveillance and can help explain enterovirus associated disease trends and warn of 
possible future outbreaks in the area 
4.1. Diversity in sewage:  
In the attempt to identify the types of enteroviruses in Edinburgh, the study revealed 
that there was a high degree of serotype diversity circulating in local sewage. A total 
of Enterovirus 31 serotypes identified. The least diverse time point was on the 23rd of 
April 2014 (Time point 3) when only six serotypes Enterovirus species were identified. 
It is likely though that this result was due to PCR issues and not really a reflection on 
what serotypes were actually present. At this time point, 12 out of 20 sequenced 
colonies identified as CVA22 in assay 1 whereas all 20 colonies in assay 3 identified 
as CVB5. PCR picking up only one serotype is one assay was one of the major 
limitations of typing by nested PCR and cloning. Similar problems were encountered 
at time points 11, 12 and 13 where one assay generated several sequences of the same 
serotype. Time point 6 (4th June 2014) on the other hand exhibited the highest level of 
diversity with a total of 16 serotypes detected. Enterovirus C104 a rare serotype was 
also identified at this time point.  
4.2. Pattern.  
Assessing the temporal pattern was one of the aims of this thesis. Due to the limited 
duration of the studies, a definitive long term temporal pattern could not be observed. 
All the three assays targeted the same region for amplification and cloning. However, 
despite the similarities in sensitivity in the detection limit assays, the data they 
generated on the same sewage samples were entirely different. This was probably due 
to preferential binding of the different antisense primers used in the various assays. 
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For example, no Enterovirus A serotypes were identified in assay 1. In assay 2 on the 
other hand, serotypes of Enterovirus A were only identified in 4 out of 13 time points 
compared to 8 out of 13 time points in assay 3. In merging these three assays, detected 
serotypes don’t appear to follow any particular pattern with respect to the season that 
the sewage samples were collected. Enterovirus B however had more diversity in all 
the time points. At time point 11, there were no Enterovirus C serotypes identified 
which a bit surprising. Enterovirus A serotypes were also not detected at time point 4.  
Enterovirus C104 was only identified twice on the 4th and 18th of June 2014. This may 
be significant as it is associated with respiratory tract infections was only detected 
twice in early summer when respiratory tract infections are quite high. No poliovirus 
strain was identified  
 
4.3. Clinical significance 
There was no concurrent diagnostic clinical data showing the types of enteroviruses 
circulating in the city during the time of study (March 2014 to September 2014). There 
has however been previous studies comparing Enterovirus species isolated in sewage 
with diagnostic clinical samples for Enterovirus surveillance in Scotland (Harvala et 
al., 2013). 
16 serotypes belonging to Enterovirus B were detected in sewage during the course 
of the study and the most common serotypes were Coxsackievirus B5 (CVB5: 
83/598), E6 (9/598), E9 (22/598), E11 (44/598), CVA9 (37/598) and E30 (30/598). 
Comparing that to the diagnostic clinical data from published in  in an article by 
Harvala et al, it appears that the six most common Enterovirus serotypes identified in 
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cerebrospinal fluid specimen collected in Edinburgh were E9, CVA9, CVB5, E6, 
E11 and E30, just like the isolates extracted from sewage during the sewage screen. 
No outbreaks however occurred during the period of study despite the fact that these 
serotypes have often been associated with large outbreaks due to appearance of new 
recombinant forms (Harvala et al., 2013).  
For species A, a total of 7 serotypes belonging to species A were detected during the 
sewage screen (CVA10, CVA6, CVA5. CVA2, Enterovirus 76 and Enterovirus 89). 
On the other hand, the serotypes identified in the cerebrospinal fluid of young 
children with sepsis like illnesses included CVA2, CVA4, CVA6, CVA10, CVA16 
and Enterovirus 71). The absence of CVA16 and Enterovirus 71 in sewage may be 
due to temporal changes in the circulation of virus in Edinburgh. CVA16 and 
Enterovirus 71 specimen were isolated between 2005 and 2010 whereas the sewage 
sample collection for this study only began in March 2014 (Harvala et al., 2013).  
 Finally, Enterovirus C serotypes were detected in all but one of the time points that 
sewage was collected and a total of 8 serotypes were detected. However, no 
Enterovirus C was detected in the clinical specimens collected from 2004 to 2012. A 
lower pathogenicity of non-polio Enterovirus C strains may be the reason for this 
dichotomy (Melnick, 2007; Harvala et al., 2013). 
 
 
4.5 Recommendations/ Future Work 
Through this project, the serotypes of enteroviruses circulating in Edinburgh have 
been identified and documented over a 6 months period using RT-PCR and gene 
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cloning. However, this opens up more possibilities to make enterovirus monitoring 
more efficient. 
First of all, a deep sequence is probably a better way of finding the types of 
enterovirus present rather than cloning and sequencing of a select number of 
colonies.  There are several Enterovirus serotypes that infect human beings and to 
select about 30 colonies after cloning is not likely to give a comprehensive overview 
of all the Enterovirus types in the sewage sample.  
Deep sequencing may be a more appropriate technique to if the intent is to find all 
the types of enterovirus present. Typing based on VP4 and partial VP2 is not 
sufficient for identifying new species. This is because, only a significant divergence 
from a reference sequence in the VP1 region can (25% nucleotide or 12% amino acid 
divergence) result in assignment of a new serotype. Since designing primers to 
amplify the VP1 genomic region for all enteroviruses is challenging, a deep 
sequencing reaction will be far more efficient and faster. 
To understand the temporal pattern, it would also be a good idea to find out the 
evolutionary changes that occur in the strains over a longer period of time. The 
nature of this project was time constrained and the significant evolutionary changes 
could not occur in that short period 
Finally, concurrent data showing clinical manifestations of enteroviruses in 
Edinburgh during the same time period as the sewage screening would be helpful in 
assessing whether there is a correlation between sewage isolates and clinical 
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